Dacarbazine bulk supplier for pharma manufacturers

Dacarbazine 100 mg/vial, 200 mg/vial Suppliers & Bulk Manufacturers

Available Forms: IV Injection

Available Strengths: 100 mg/vial, 200 mg/vial

Reference Brands: DTIC-Dome®(EU & US)

Dacarbazine, branded as DTIC-Dome® (US) and available in generic form, is used to treat malignant melanoma, Hodgkin’s lymphoma, and soft tissue sarcoma. As an alkylating agent, it interferes with DNA replication, preventing cancer cell growth. Available in 100 mg and 200 mg vials for IV injection, Dacarbazine is sourced from GMP-compliant suppliers and is widely used in US and EU markets for oncology treatment.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Dacarbazine? List it or send an offer →

Product Description: Dacarbazine, marketed as DTIC-Dome® (by Bristol-Myers Squibb) and available as a generic in the US and EU, is an alkylating agent used in the treatment of malignant melanoma, Hodgkin’s lymphoma, and soft tissue sarcoma. Available in 100 mg and 200 mg vials for IV injection, Dacarbazine interferes with DNA replication, preventing cancer cell division. As a trusted oncology therapy, it is sourced from GMP-compliant suppliers and is a key treatment option for oncologists targeting aggressive cancers. Dacarbazine is widely available in global US and EU markets for hospital and clinic use.

Dacarbazine — third party manufacturing & bulk supply

Dacarbazine 100 mg/vial, 200 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Dacarbazine is supplied as IV Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Dacarbazine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Dacarbazine →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Dacarbazine is listed as IV Injection in 100 mg/vial, 200 mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Dacarbazine is referenced against DTIC-Dome®(EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.